A Randomized, Open Label, Single Dose, 6 Treatment, 4-way Crossover Study in Healthy Subjects to Assess the Pharmacokinetics of Three Different Particle Sizes of PH-797804 Tablet With and Without the Solubilizing Agent Sodium Lauryl Sulphate (SLS)
Status: Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 19 Dec 2013
Price : $35 *
At a glance
- Drugs PH 797804 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 19 Dec 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 07 Oct 2013 Planned End Date changed from 1 Oct 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 07 Oct 2013 Planned initiation date changed from 1 Sep 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.